Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-238326
Filing Date
2025-10-14
Accepted
2025-10-14 08:59:40
Documents
1
Period of Report
2025-10-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7145
  Complete submission text file 0001193125-25-238326.txt   8690
Mailing Address CO LONGITUDE CAPITAL PARTNERS LLC 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025
Business Address
ENRIGHT PATRICK G (Reporting) CIK: 0001253886 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42270 | Film No.: 251389959

Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Issuer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)